You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
恆指倒跌逾260點略失二萬七 騰訊/美團/安踏/藥明生物續捱沽 惟舜宇逆漲逾半成
本港失業率連降四個月,截至6月三個月由前值6%,續降至5.5%,遠勝市場預期5.8%。不過,恆指逆外圍及區內三連跌,今早在比亞迪(01211.HK)、阿里(09988.HK)、舜宇(02382.HK)和申洲(02313.HK)高開逾1%-2%支撐,高開79點或0.3%報27,339,最多回升112點高見27,371無以為繼,在重磅新經濟股騰訊(00700.HK)與美團(03690.HK)下挫及金融股全面受壓拖累,掉頭重失牛熊線(27,177),曾倒跌288點,低見26,971(暫守穩7月盤中所創年內低位26,861),現造26,994,倒跌264點或1%,成交額735億元。

藍籌股普遍反覆受壓,重磅股騰訊四連跌,股價今早反彈至544.5元無以為繼,掉頭低見530元,現造532.5元,倒跌1.8%;美團三連跌,最低見267元,現造269元,續跌2.3%:小米(01810.HK)反覆三連跌,今早股價高開見27.9元遇阻,掉頭失守20天、10天及50天線(26.95-27.4元),最低見26.6元,現造26.8元,續跌2.9%。

藥明生物(02269.HK)遭主要股東Biologics折讓6.5%每股129元減持八千萬股上板,該股三連跌,今早失守10天及20天線,最低見131.8元,現造133元,續跌3.6%。安踏(02020.HK)由紀錄高位反覆四連跌,今早高開回升至見186.9元乏力,掉頭失守20天線(182.5元),最低見175.5元,現造177元,續跌3.6%。

蘋果昨晚回升逾2%,舜宇(02382.HK)重越10天及20天線(226.4元及233元),最高見236元,現造235元,回升5.4%,為最強藍籌。

長汽(02333.HK)業績快報中期多賺逾2倍,刺激股價急漲12%至30.6元,連帶比亞迪(01211.HK)及吉利(00175.HK)也反彈2.9%及1.7%,分別高見215.2元及23.75元,前者股價結束五連跌。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account